Children are given vaccinations to train their immune systems to fight dangerous infections before they ever encounter them naturally. This matters most in childhood because young immune systems are still developing, and diseases like measles, whooping cough, and polio pose the greatest risk of serious complications in the first years of life. Since 1994, routine childhood vaccinations in the United States have prevented roughly 508 million cases of illness, 32 million hospitalizations, and over 1.1 million deaths.
How Vaccines Teach the Immune System
Your body defends itself using white blood cells, which are produced in bone marrow and spread throughout the body in small numbers, ready to multiply when they detect something foreign. When these cells encounter a virus or bacterium, they produce proteins called antibodies that lock onto the invader and neutralize it. After the infection clears, most of those white blood cells die off, but a few remain on patrol. Those remaining cells are memory cells, and they’re the reason you rarely get the same illness twice.
Vaccines take advantage of this system by exposing the body to killed or weakened versions of a pathogen, or even just key pieces of one. The immune system responds the same way it would to a real infection: it multiplies white blood cells, produces antibodies, and creates memory cells. The difference is that the child never has to get sick. If they later encounter the actual disease, their immune system recognizes it immediately and shuts it down before symptoms develop.
Why Timing Starts So Early
Newborns arrive with some borrowed protection. During pregnancy, a mother passes her own antibodies to the baby, providing a temporary shield. But those maternal antibodies fade over 6 to 12 months, leaving the infant increasingly vulnerable. At the same time, an infant’s own immune system is still immature and not fully capable of mounting strong responses until around 12 months of age.
This creates a narrow window. Vaccines are scheduled to begin at about 2 to 3 months of age, once the infant’s immune system is developed enough to respond to a vaccine but before maternal protection has fully worn off. Some vaccines, like hepatitis B, are given at birth because the risk of infection is immediate. Others, like the measles, mumps, and rubella (MMR) vaccine, wait until 12 months because maternal antibodies can actually interfere with the vaccine’s effectiveness if given too early. The schedule isn’t arbitrary. Each vaccine is timed to the point where it will work best and where the child needs it most.
The current U.S. schedule recommends the first dose of hepatitis B at birth, diphtheria/tetanus/whooping cough and polio vaccines at 2 months, and the first MMR dose at 12 months.
What These Diseases Actually Do
It’s easy to underestimate childhood diseases when you’ve never seen them, and that’s largely because vaccines have made them rare. But the complications they cause are severe. Measles can lead to pneumonia, brain damage, and death. Mumps can cause swelling of the testicles or ovaries, permanent deafness, and inflammation of the brain. Rubella during pregnancy causes devastating birth defects.
Before vaccines, these weren’t uncommon outcomes. They were expected. Polio paralyzed thousands of children every year. Whooping cough killed infants who couldn’t yet breathe well enough to survive the coughing fits. The point of vaccination isn’t just to prevent a fever and a rash. It’s to prevent the rare but catastrophic complications that follow these infections, complications that are far more dangerous than any side effect a vaccine could cause.
The Numbers Behind Disease Reduction
After the measles vaccine was licensed, reported cases dropped by 22% each year. Rubella and polio followed with annual decreases of 16% and 15%, respectively. These aren’t small shifts. Compounded over decades, they represent the near-elimination of diseases that once filled hospital wards.
The economic case is equally striking. A CDC analysis of children born between 1994 and 2023 found that routine childhood vaccinations saved $540 billion in direct medical costs and $2.7 trillion in broader societal costs after accounting for the cost of the vaccines themselves. That works out to roughly $11 saved for every $1 spent on immunization.
Protecting Children Who Can’t Be Vaccinated
Not every child can receive vaccines. Some have immune conditions, are too young for certain doses, or have allergies to vaccine components. These children depend on everyone around them being vaccinated, a concept known as herd immunity. When enough people in a community are immune, the disease can’t find new hosts and stops spreading, which indirectly protects those who are vulnerable.
The threshold varies by disease. Measles is extraordinarily contagious, so about 95% of the population needs to be immune to stop it from spreading. Polio requires around 80%. When vaccination rates drop below these thresholds, outbreaks return, and they hit unvaccinated children hardest. Vaccinating your child doesn’t just protect them. It protects infants in the waiting room, classmates undergoing chemotherapy, and neighbors with compromised immune systems.
How Vaccine Safety Is Established
Childhood vaccines go through a layered testing process before they reach a pediatrician’s office. They’re first tested in adults, then stepped down to children and infants. Phase 1 trials involve 20 to 100 healthy volunteers and focus on identifying adverse reactions at increasing doses. Phase 2 expands to hundreds of participants with varying health backgrounds, testing different dosages and tracking short-term side effects. Phase 3 enrolls thousands, comparing vaccinated participants against a control group to measure both effectiveness and less common side effects.
Even after approval, vaccines are continuously monitored through multiple surveillance systems. These track reports of adverse events across millions of doses and can detect patterns that clinical trials, limited by sample size, might miss.
What Side Effects Look Like
Most vaccine side effects are mild and short-lived. Across all childhood vaccines, about 74% of all reported adverse events involve local reactions (soreness or redness at the injection site), low-grade fever, or rash. These typically resolve within a day or two and are signs the immune system is responding.
Serious reactions are rare. Reporting rates for events following MMR-containing vaccines run about 75 to 84 reports per million doses, and the vast majority of those reports are the mild reactions described above. Severe outcomes like encephalitis occur at very low rates that are similar across all vaccine types. Febrile seizures, which are brief convulsions triggered by fever, are the most commonly reported serious event, and even these resolve without lasting harm in nearly all cases. The risk of complications from the diseases themselves is orders of magnitude higher than the risk from the vaccines that prevent them.